Information for institutional quotation
Cardiogen: price, documentation and dispatch in Colombia
Cardiogen is listed under the commercial category "Other catalog compounds," with a single presentation — 20 mg vial — from US$215. That category label, however, is not the whole story: Cardiogen's structural classification places it within the short peptide bioregulator family, a group of seven synthetic references of very few amino acids that the catalog documents as a separate set, even though the commercial filter does not group them all under one name. This page explains that dual classification, the current presentation and price, and how a lot's identity is confirmed through the certificate Janoshik Analytical issues, always within the framework of reference material for research and laboratory work.
Presentations and visible prices
| Presentation | Code | Reference price |
|---|---|---|
| 20mg | * | US$215 |
The price above is the public value per vial. Availability and batch documentation are confirmed before the quotation is accepted.
Why the sales category and the structural family do not match
Cardiogen inherits the category "Other catalog compounds" from the original commercial field, a catch-all that groups references with no dedicated thematic label. But its technical descriptor — short synthetic peptide from the peptide bioregulator family — links it directly to six other catalog references that share exactly the same structural classification: Bronchogen, Cartalax, Cortagen, Crystagen, Pinealon, and Vesugen.
That group of seven was not identified as a family anywhere in the commercial catalog until the site's technical taxonomy brought them together for the first time. This page carries that same distinction forward: it describes Cardiogen within its real structural family, without promising that the sales category will change or inventing a relationship other than the one already stated in the published classification.
Cardiogen's 20 mg presentation: what to state in the quote
The catalog offers Cardiogen in a single presentation, 20 mg vial, with a current listed price from US$215. Within the short peptide bioregulator family, the 20 mg vial is the usual presentation: several references in that same group are also offered in 5 and 10 mg, although this page does not set those other references' figures, which are confirmed individually in each one's own commercial block.
Cardiogen's starting price is always confirmed in this page's commercial block before approving any quote, without assuming it matches another catalog reference — whether from its own bioregulator family or any other category — or an earlier inquiry.
Lot identity: the role of the Janoshik Analytical certificate
As with the rest of the catalog, the identity and purity of a Cardiogen lot are not inferred from the name or from the structural classification stated on this page. They are confirmed by the certificate of analysis (COA) that Janoshik Analytical issues per lot, combining high-performance liquid chromatography (HPLC) for purity and mass spectrometry (MS) for identity.
Access to the COA is on request and subject to documentary availability, and it must correspond to the specific lot being shipped, not to the reference in general. This page does not assign Cardiogen a purity figure, a CAS number, a molecular formula, or a molecular weight: those are data that, if they exist, are in the lot's documentation, and if unavailable, remain visibly pending on the technical page rather than being filled in by similarity with another short peptide from the same family.
Physical form and declared storage conditions
Cardiogen's 20 mg vial corresponds to the powder presentation characteristic of this short-peptide family, the same physical form shared by Bronchogen, Cartalax, Cortagen, Crystagen, Pinealon, and Vesugen within the catalog, as opposed to solution formats such as Insulin or LC216.
The storage condition stated on the site's technical sheet for the peptide catalog is 2–8 °C, protected from light. That condition should be verified against the specific documentation of the lot received before assigning laboratory custody space, and should not be assumed guaranteed just because it appears in the general technical block.
From the catalog to the institutional quote
Adding Cardiogen to a request does not trigger an immediate charge: the catalog works by quote. The request is first recorded with the 20 mg presentation and the current price; the commercial confirmation that follows sets the total, the shipping destination, and the payment method in writing. Transport is calculated separately from the material's price, with rates for Bogotá and for the rest of the country shown on the site's shipping information, and delivery time confirmed at that stage. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.
The purchase file can gather the accepted quote, the proof of payment, the shipping confirmation, the receiving record, and the COA when requested. If a document is not available at the time of purchase, the correct approach is to flag it as pending in the internal file, not to fill it in with data from another reference in the same family.
Cardiogen against its six family peers
Bronchogen, Cartalax, Cortagen, Crystagen, Pinealon, and Vesugen share the same structural descriptor as Cardiogen — short synthetic peptide from the peptide bioregulator family — without the catalog distinguishing between them by declared composition. What does distinguish each one on its own page is its catalog code, its presentation, and its own price, which must be confirmed separately for each reference.
This page does not describe Cardiogen as more or less representative of the group than its peers: all seven carry the same documented structural classification. The practical difference for an institutional purchase lies in which code, which presentation, and which price correspond to the specific request, not in any hierarchy within the family.
Frequently asked questions about Cardiogen
Why does Cardiogen appear under "Other catalog compounds" if it has a molecular family?
Because the commercial category inherits the original source classification, while the structural family — short peptide bioregulators, along with Bronchogen, Cartalax, Cortagen, Crystagen, Pinealon, and Vesugen — is a separate technical classification that the catalog documents on its own.
What presentation and price does Cardiogen have?
20 mg vial, with a current listed price from US$215. It is the only presentation registered for this reference.
How is the identity of a Cardiogen lot confirmed?
With the certificate of analysis (COA) that Janoshik Analytical issues per lot: HPLC for purity and mass spectrometry for identity. It is handled on request and subject to documentary availability.
Is Cardiogen similar to Bronchogen, Cortagen, or Vesugen?
It shares with them the same structural classification — short synthetic peptide from the peptide bioregulator family — but each reference keeps its own code, presentation, and price in the catalog.
How much does shipping cost for an order with Cardiogen?
Rates for Bogotá and for the rest of the country are shown on the site's shipping information. Delivery time is confirmed together with the institutional quote. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.